Results 21 to 30 of about 5,879 (222)

An overview on application of phage display technique in immunological studies

open access: yesAsian Pacific Journal of Tropical Biomedicine, 2017
Phage display is very strong technique in drug discovery and development. Phage display has many applications in improving the immunological studies. Development of monoclonal antibody, peptides, peptidomimetics and epitope mapping are main application ...
Abbas Rami   +4 more
doaj   +1 more source

VNAR development through antigen immunization of Japanese topeshark (Hemitriakis japanica)

open access: yesFrontiers in Bioengineering and Biotechnology, 2023
The VNAR (Variable New Antigen Receptor) is the smallest single-domain antibody derived from the variable domain of IgNAR of cartilaginous fishes. Despite its biomedical and diagnostic potential, research on VNAR has been limited due to the difficulties ...
Hiroyuki Takeda   +13 more
doaj   +1 more source

Biopanning of allergens from wasp sting patients [PDF]

open access: yesBioscience Reports, 2018
Objective: Wasp venom is a potentially important natural drug, but it can cause hypersensitivity reactions. The purpose of the present study was to systematically study the epitopes of wasp venom. Methods: Using a random 12-peptide phage library, we performed antibody-binding epitope panning on ten serum samples from wasp sting victims at 3 h and 4 ...
Chai, Lin   +10 more
openaire   +2 more sources

Generation of Lamprey Monoclonal Antibodies (Lampribodies) Using the Phage Display System. [PDF]

open access: yes, 2019
The variable lymphocyte receptors (VLRs) consist of leucine rich repeats (LRRs) and comprise the humoral antibodies produced by lampreys and hagfishes.
Amemiya, Chris T   +3 more
core   +2 more sources

Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors

open access: yesBrazilian Journal of Infectious Diseases, 2012
OBJECTIVE: One approach to identifying HIV-1 vaccine candidates is to dissect the natural antiviral immune response in treatment-naïve individuals infected for over ten years, considered slow progressor patients (SPs).
Xiaoli Zhang   +9 more
doaj   +1 more source

Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors

open access: yesBrazilian Journal of Infectious Diseases, 2012
OBJECTIVE: One approach to identifying HIV-1 vaccine candidates is to dissect the natural antiviral immune response in treatment-naïve individuals infected for over ten years, considered slow progressor patients (SPs).
Xiaoli Zhang   +9 more
doaj   +3 more sources

The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs [PDF]

open access: yes, 2005
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnostics, but the efficacies of these treatments are limited in part by the size of the molecules and non-specific uptake by the reticuloendothelial system ...
Lauren R.H. Krumpe   +89 more
core   +1 more source

Characterization of the Binding Behavior of Specific Cobalt and Nickel Ion-Binding Peptides Identified by Phage Surface Display

open access: yesSeparations, 2022
In recent years, the application focus of phage surface display (PSD) technology has been extended to the identification of metal ion-selective peptides. In previous studies, two phage clones—a nickel-binding one with the peptide motif CNAKHHPRCGGG and a
Sabine Matys   +3 more
doaj   +1 more source

The Application of Next Generation Sequencing in Phage Display: A Short Review [PDF]

open access: yesImmunoAnalysis, 2021
Phage display is a method of studying protein-protein, protein-peptide, and protein-DNA that uses bacteriophages to bind proteins with genetic information that encodes them.
Ali Aghebati-Maleki   +4 more
doaj   +1 more source

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside

open access: yesFrontiers in Immunology, 2020
Monoclonal antibodies (mAbs) have become one of the most important classes of biopharmaceutical products, and they continue to dominate the universe of biopharmaceutical markets in terms of approval and sales.
Mohamed A. Alfaleh   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy